Patents by Inventor SUZY COHEN
SUZY COHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230346751Abstract: The present disclosure relates to dietary supplements, for improving dermatological health. In embodiments, the composition is comprised of D-Biotin, grape seed extract, superoxide dismutase, zinc, Vitamin C, Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus rhamnosus, or combinations/sub-combinations thereof.Type: ApplicationFiled: July 3, 2023Publication date: November 2, 2023Inventor: Suzy Cohen
-
Publication number: 20220110918Abstract: The present disclosure relates to dietary supplements, for improving dermatological health. In embodiments, the composition is comprised of D-Biotin, grape seed extract, superoxide dismutase, zinc, Vitamin C, Lactobacillus Plantarum, Lactobacillus Reuteri, Lactobacillus Rhamnosus, or combinations/sub-combinations thereof.Type: ApplicationFiled: October 12, 2021Publication date: April 14, 2022Inventor: Suzy Cohen
-
Patent number: 11273191Abstract: The present disclosure relates to methods of administering a composition to a patient, particularly in the form of a dietary supplement, which addresses immune system deficiencies and promotes healthy immune system functioning. The present disclosure also related to compositions and methods for improving or boosting immune system functioning. The present disclosure further provides novel compositions for balancing immune response in human subjects.Type: GrantFiled: March 30, 2020Date of Patent: March 15, 2022Assignee: Script Essentials, LLCInventor: Suzy Cohen
-
Publication number: 20220023398Abstract: The present disclosure relates to methods of administering a compound for treating a patient suffering from thyroid disease and various thyroid-related disorders, including hyperthyroid and hypothyroid. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet.Type: ApplicationFiled: October 7, 2021Publication date: January 27, 2022Inventor: Suzy Cohen
-
Publication number: 20210299197Abstract: The present disclosure relates to methods of administering a composition to a patient, particularly in the form of a dietary supplement, which addresses immune system deficiencies and promotes healthy immune system functioning. The present disclosure also related to compositions and methods for improving or boosting immune system functioning. The present disclosure further provides novel compositions for balancing immune response in human subjects.Type: ApplicationFiled: March 30, 2020Publication date: September 30, 2021Inventor: Suzy Cohen
-
Publication number: 20210267911Abstract: The present disclosure relates to compositions for improving vision in a patient and methods of administering a composition to a patient, particularly in the form of a dietary supplement, which addresses vision impairment and promotes the health of a patient experiencing problems associated with deteriorated eyesight, including macular degeneration. The present disclosure also relates to methods for formulating the composition described herein.Type: ApplicationFiled: November 16, 2020Publication date: September 2, 2021Inventor: Suzy Cohen
-
Patent number: 10709746Abstract: The present disclosure is a compound, a method of making the compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of supporting memory, focus, and clarity. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least Hericium Erinaceus, Bacopa Monnieri, ECGC (Epigallocatechin-3-Gallate), Huperzine, Acetyl-L-Carnitine, Vitamin B12, Ginkgo Biloba, Phosphatidylserine, and Gotu Kola, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.Type: GrantFiled: May 30, 2018Date of Patent: July 14, 2020Inventor: Suzy Cohen
-
Patent number: 10702590Abstract: The present disclosure relates to a compound and method of using such compound, preferably in the form of a dietary supplement that, when administered, is capable of treating thyroid disease and various thyroid-related disorders, such as Hashimoto's thyroiditis. The unique combination of the composition is preferably administered orally via acid resistant or enteric-coated capsule, soft gel or tablet. The composition is preferably comprised of at least Catalase, Reduced Glutathione, Acetylated Glutathione, DPP-IV protease enzyme, Pepsin, Bromelain, Pancreatin, Vitamin D, and Selenium. The composition can further comprise a palliative agent, and can be provided in specific dosages or administered in forms besides those listed above.Type: GrantFiled: April 4, 2017Date of Patent: July 7, 2020Assignee: Script Essentials, LLCInventor: Suzy Cohen
-
Publication number: 20200038341Abstract: The present disclosure relates to a compound, method of making and method of using such compound preferably in the form of a dietary supplement. The composition, when administered, is capable of treating arthritis and various joint-related pain syndromes. The unique combination of the composition is preferably administered orally. A preferred composition is comprised of at least 10 to 200 mcg of selenium, from about 200 to 1200 mg of MSM, from about 100 to 900 mg of boswellia, from about 1 to 5 mg of type II collagen, from about 25 to 200 mg of hyaluronic acid, and from about 50 to 500 mg of ginger.Type: ApplicationFiled: October 15, 2019Publication date: February 6, 2020Applicant: Script Essentials, LLCInventor: Suzy Cohen
-
Patent number: 10369182Abstract: The present disclosure is a composition, a method of making the composition and method of using such composition preferably in the form of a dietary supplement that, when administered, is capable of treating insomnia and other sleep-related disorders. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least vitamin B6, chamomile extract, passionflower extract, lemon balm extract, L-Theanine, GABA, 5-Hydroxytryptophan, and melatonin, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.Type: GrantFiled: July 3, 2018Date of Patent: August 6, 2019Assignee: SCRIPT ESSENTIALS, LLCInventor: Suzy Cohen
-
Publication number: 20190134165Abstract: The present disclosure relates to a compound and method of administering such compound for treating a patient suffering from thyroid disease and various thyroid-related disorders, including hyperthyroid and hypothyroid. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet.Type: ApplicationFiled: January 2, 2019Publication date: May 9, 2019Inventor: Suzy Cohen
-
Publication number: 20190000907Abstract: The present disclosure is a composition, a method of making the composition and method of using such composition preferably in the form of a dietary supplement that, when administered, is capable of treating insomnia and other sleep-related disorders. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least vitamin B6, chamomile extract, passionflower extract, lemon balm extract, L-Theanine, GABA, 5-Hydroxytryptophan, and melatonin, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.Type: ApplicationFiled: July 3, 2018Publication date: January 3, 2019Inventor: Suzy Cohen
-
Publication number: 20180369306Abstract: The present disclosure is a compound, a method of making the compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of supporting memory, focus, and clarity. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least Hericium Erinaceus, Bacopa Monnieri, ECGC (Epigallocatechin-3-Gallate), Huperzine, Acetyl-L-Carnitine, Vitamin B12, Ginkgo Biloba, Phosphatidylserine, and Gotu Kola, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.Type: ApplicationFiled: May 30, 2018Publication date: December 27, 2018Inventor: Suzy Cohen
-
Patent number: 10154681Abstract: The present disclosure relates to a compound, method of making the compound, method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of use by any individuals, including patients having thyroid disease or various thyroid-related disorders. The unique combination of the composition is preferably administered orally, and preferably in the form of a drink. In some embodiments, the composition includes at least organic chlorella, organic dulse, organic acai, organic carrot, organic pineapple, apple pectin, organic inulin, PR-4 probiotic strain—preferably “Bacillus Coagulans,” organic wheat grass, organic beet root, organic ulva, organic evaporated cane juice, natural flavorsweet flavor, sodium chloride, citric acid, organic guar gum, creamy vanilla flavor, natural raspberry flavor, and natural mixed berry flavor.Type: GrantFiled: November 3, 2016Date of Patent: December 18, 2018Assignee: Script Essentials, LLCInventor: Suzy Cohen
-
Publication number: 20180085382Abstract: The present disclosure is a compound, a method of making the compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of treating heart disease and heart-related disorders, among other symptoms. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of about 1,000 to 5,000 IU of vitamin D, preferably cholecalciferol, about 250 to 1,250 mg of fish oil concentrate, about 200 to 1,200 mg of omega-3 fatty acids, about 200 to 700 mg of DHA, about 20 to 125 mg of EPA, and about 10 to 150 mg of other fatty acids. The composition can further comprise a palliative agent, and can be provided in the form of a softgel, powder, liquid or tablet.Type: ApplicationFiled: September 18, 2017Publication date: March 29, 2018Inventor: Suzy Cohen
-
Publication number: 20170290894Abstract: The present disclosure relates to a compound and method of using such compound, preferably in the form of a dietary supplement that, when administered, is capable of treating thyroid disease and various thyroid-related disorders, such as Hashimoto's thyroiditis. The unique combination of the composition is preferably administered orally via acid resistant or enteric-coated capsule, soft gel or tablet. The composition is preferably comprised of at least Catalase, Reduced Glutathione, Acetylated Glutathione, DPP-IV protease enzyme, Pepsin, Bromelain, Pancreatin, Vitamin D, and Selenium. The composition can further comprise a palliative agent, and can be provided in specific dosages or administered in forms besides those listed above.Type: ApplicationFiled: April 4, 2017Publication date: October 12, 2017Applicant: SCRIPT ESSENTIALS, LLCInventor: Suzy Cohen
-
Publication number: 20170266130Abstract: The present disclosure relates to a compound, method of making and method of using such compound preferably in the form of a dietary supplement. The composition, when administered, is capable of treating arthritis and various joint-related pain syndromes. The unique combination of the composition is preferably administered orally. A preferred composition is comprised of at least 10 to 200 mcg of selenium, from about 200 to 1200 mg of MSM, from about 100 to 900 mg of boswellia, from about 1 to 5 mg of type II collagen, from about 25 to 200 mg of hyaluronic acid, and from about 50 to 500 mg of ginger.Type: ApplicationFiled: December 27, 2016Publication date: September 21, 2017Applicant: Script Essentials, LLCInventor: Suzy Cohen
-
Publication number: 20170127701Abstract: The present disclosure relates to a compound, method of making the compound, method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of use by any individuals, including patients having thyroid disease or various thyroid-related disorders. The unique combination of the composition is preferably administered orally, and preferably in the form of a drink. In some embodiments, the composition includes at least organic chlorella, organic dulse, organic acai, organic carrot, organic pineapple, apple pectin, organic inulin, PR-4 probiotic strain—preferably “Bacillus Coagulans,” organic wheat grass, organic beet root, organic ulva, organic evaporated cane juice, natural flavorsweet flavor, sodium chloride, citric acid, organic guar gum, creamy vanilla flavor, natural raspberry flavor, and natural mixed berry flavor.Type: ApplicationFiled: November 3, 2016Publication date: May 11, 2017Inventor: Suzy Cohen
-
Publication number: 20170056463Abstract: The present disclosure is a compound, a method of making the compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of treating prediabetes, diabetes, insulin resistance or metabolic syndrome. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least vitamin D, gamma tocopherol, niacin, folate, chromium, zinc, magnesium, potassium, bilberry, resveratrol, holy basil and berberine, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.Type: ApplicationFiled: September 1, 2016Publication date: March 2, 2017Inventor: Suzy Cohen
-
Publication number: 20160339086Abstract: The present disclosure relates to a compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of treating thyroid disease and various thyroid-related disorders. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet.Type: ApplicationFiled: May 17, 2016Publication date: November 24, 2016Inventor: SUZY COHEN